Tissular Distribution of Argentinean Strains of Bovine Herpesvirus Type 4 (BoHV-4) in Experimentally-Infected Calves

Bovine herpesvirus type 5 (BoHV-5) belongs to the family Herpesviridae, subfamily Alphaherpesvirinae, genus Varicellovirus. This virus is a major causative agent of non-suppurative meningoencephalitis in young cattle. It was first isolated in 1962 from a neurological disease outbreak in Australia. BoHV-5 is genetically and antigenically related to bovine herpesvirus type 1 (BoHV-1), a highly prevalent virus responsible for respiratory and genital disease in cattle. Initially, BoHV-5 was considered a subtype of BoHV-1 (BoHV-1.3). However, the exclusive presentation of outbreaks of neurological disease suggested that the virus was a new agent with characteristics of neuropathogenicity. Even though both are neurotropic viruses, only BoHV-5 is capable of replicating extensively in the central nervous system and inducing neurological disease. Occasionally, encephalitis caused by BoHV-1 has been reported. Like other alpha-herpesviruses, BoHV-5 can establish latency in nervous ganglia and, by stress factors or glucocorticoid treatment, latent virus can be reactivated. During episodes of reactivation, the virus is excreted in nasal, ocular and genital secretions and transmitted to other susceptible hosts. Recently, BoHV-5 has been associated with infection of the reproductive tract. The virus has been isolated and the presence of viral DNA has been demonstrated in semen samples from Brazil and Australia and natural transmission of the virus through contaminated semen has also been described. Embryos and oocytes are permissive for BoHV-5 infection and BoHV-5 DNA has been detected in the central nervous system of aborted fetuses. The objective of this review is to compile the limited information on the recent association between BoHV-5 and reproductive disorders in cattle.

Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine

Latency of bovine herpesvirus type 5 (BoHV-5) in tonsils and peripheral blood leukocytes

Bovine herpesvirus type 1 (BHV-1) is an important component of the bovine respiratory disease complex (BRDC) in cattle. Following primary intranasal and ocular infection of cattle, BHV-1 establishes lifelong latent infection in trigeminal ganglia (TG). Upon reactivation from latency, the virus is transported from neuronal cell bodies in the TG to projected nerve endings in nose and cornea of latently infected cattle where the virus shedding occurs. This property of BHV-1 plays a significant role in the pathogenesis of BRDC and maintenance of BHV-1 in the cattle population. Recently, we have reported that a glycoprotein E (gE) cytoplasmic tail-truncated BHV-1 (BHV-1 gEAm453) did not reactivate from latency and was not shed in the nasal and ocular secretions of calves and rabbits. Here we describe the methods to establish rabbit primary dorsal root ganglia (DRG) neuron cultures in a microfluidic chamber system and to characterize in vitro anterograde and retrograde axonal transport properties of BHV-1 gE-deleted and BHV-1 cytoplasmic tail-truncated gEAm453 mutant viruses relative to BHV-1 gEAm453-rescued/wild-type viruses. The results clearly demonstrated that whereas the BHV-1 gE-deleted, BHV-1 gEAm453, and BHV-1 gEAm453-rescued/wild-type viruses were transported equally efficiently in the retrograde direction, only the BHV-1 gEAm453-rescued/wild-type virus was transported anterogradely. Therefore, we have concluded that sequences within the BHV-1 gE cytoplasmic tail are essential for anterograde axonal transport and that primary rabbit DRG neuronal cultures in the microfluidic chambers are suitable for BHV-1 neuronal transport studies.

Distribution of bovine herpesvirus type 1 in the nervous system of experimentally infected calves

Bovine Herpes Virus Type 1 Oncolytic Therapy Elicits Direct Cytotoxic Effects and Immune Microenvironment Reshaping in Multiple Myeloma

The bovine herpesvirus type 1 (BHV‐1) is a pathogen of great economic impact for livestock, which is related multi‐systemic infections that leads to mortality or morbidity of cattles. Thus, the search for cheap and practical methodologies that allow the selective detection of BHV‐1 antigen (BHV‐1 AG) is of utmost relevance. Therefore, an impedimetric label‐free immunosensor was herein, developed and its performance evaluated in biological samples enriched with BHV‐1 AG. Briefly, the biosensor construction was based on the immobilization of BHV‐1 antibody (BHV‐1 AB) and casein on the activated glassy carbon electrode surface. The BHV‐1 AB was isolated from egg yolk of immunized chickens, which is a less stressful protocol. The bio sensing principle was based on Electrochemical Impedance Spectroscopy by using Fe(CN)64−/3− probe, which were also used to check variation of charge transfer resistance (▵Rct), when the electrode surface was increasingly blocked by immune complex. A linear relationship between ▵Rct and BHV‐1 AG concentration was verified in the range from 10 to 50 TCID50 mL−1, with LOQ of 2.00 TCID50 mL−1 and LOD of 0.66 TCID50 mL−1. Besides the suitable sensitivity, the immunosensor displayed accuracy, stability, and specificity to detect BHV‐1 AG in biological samples of serum, nasal secretions, semen and urine. Moreover, to the best of our knowledge this is the first immunosensor applied to BHV‐1 diagnostic.

Bovine herpesvirus type 1 (BHV-1) is a major cause of reproductive failure. A study was conducted to determine if vaccination with a modified-live virus (MLV) vaccine containing BHV-1 at either 8 or 13 months prior to challenge protects against BHV-1 challenge-induced abortion. A total of 51 beef heifers, seronegative to bovine viral diarrhea virus types 1 and 2 and BHV-1, were vaccinated subcutaneously with a commercially available combination MLV vaccine containing BHV-1 and inactivated bacterin vaccine, or placebo containing bacterin only. The estrus cycle was synchronized and heifers wereartificially inseminated approximately 6 or 1 month(s) after vaccination. Heifers were challenge-inoculated intravenously at approximately 193 days of gestation with a virulent BHV-1 virus. Clinical signs of BHV-1 infection were monitored for 14 days following challenge. Serological status and occurrence of abortion or stillbirth were also determined. Tissues collected from aborted fetuses (n = 22) and full-term calves that were born dead (i.e., stillbirth [n = 1] or dystocia [n = 2]) were tested for BHV-1 via virus isolation. BHV-1 was isolated from 1 fetus (7.7%) from Treatment Group 1 heifers (TGl -heifers challenged 13 months after BHV-1 MLV vaccination), from 3 fetuses/calves (15.8%) from Treatment Group 2 heifers (TG2 - heifers challenged 8 months after BHV-1 MLV v~ccination), and from 7 fetuses (36.8%) from Treatment Group 3 heifers (TG3 - control heifers that rec~ived bacterin only). Polymerase chain reaction testing results indicated that 1 fetus from the 13 (7. 7%) TG 1 heifers, 5 fetuses out of the 19 (26.3%) TG2 heifers, and 18 fetuses out of the 19 (94.7%) TG3 control heifers were BHV-1 positive. In this study, a combination MLV vaccine containing BHV-1 administered 8 or 13 months prior to challenge provided a significant level of protection against fetal infection in the face of a substantial challenge infection with BHV-1 when compared to nonvaccinated controls.

Assessment of the risk of transmission of vaccine viruses by using insufficiently cleaned injection devices

Bovine herpesvirus type 5 (BoHV-5) is an important pathogen of cattle in South America. We describe here the construction and characterization of deletion mutants defective in the glycoprotein E (gE) or thymidine kinase (TK) gene or both (gE/TK) from a highly neurovirulent and well-characterized Brazilian BoHV-5 strain (SV507/99). A gE-deleted recombinant virus (BoHV-5 gE) was first generated in which the entire gE open reading frame was replaced with a chimeric green fluorescent protein gene. A TK-deleted recombinant virus (BoHV-5 TK) was then generated in which most of the TK open reading frame sequences were deleted and replaced with a chimeric beta-galactosidase gene. Subsequently, using the BoHV-5 gE virus as backbone, a double gene-deleted (TK plus gE) BoHV-5 recombinant (BoHV-5 gE/TK) was generated. The deletion of the gE and TK genes was confirmed by immunoblotting and PCR, respectively. In Madin Darby bovine kidney (MDBK) cells, the mutants lacking gE (BoHV-5 gE) and TK + gE (BoHV-5 gE/TK) produced small plaques while the TK-deleted BoHV-5 produced wild-type-sized plaques. The growth kinetics and virus yields in MDBK cells for all three recombinants (BoHV-5 gE, BoHV-5 TK and BoHV-5 gE/TK) were similar to those of the parental virus. It is our belief that the dual gene-deleted recombinant (BoHV-5 gE/TK) produced on the background of a highly neurovirulent Brazilian BoHV-5 strain may have potential application in a vaccine against BoHV-5.

Coelhos são susceptíveis à infecção pelo herpes-vírus bovino tipo 5 (BHV-5) e freqüentemente desenvolvem enfermidade neurológica aguda fatal após inoculação intranasal. A cinética da invasão do sistema nervoso central (SNC) de coelhos pelo BHV-5 foi estudada através de pesquisa de vírus em secções do SNC a diferentes intervalos pós-inoculação. Após inoculação intranasal, o vírus foi inicialmente detectado no bulbo olfatório às 48h, seguido do córtex olfatório às 48/72h. Às 72/96h o vírus foi detectado também no gânglio trigêmeo, ponte e córtex cerebral. Dois experimentos foram realizados para avaliar a importância do sistema olfatório na invasão do SNC de coelhos pelo BHV-5. No primeiro experimento, coelhos foram inoculados com duas amostras do BHV-5 no saco conjuntival. Coelhos inoculados por essa via também desenvolveram a enfermidade neurológica, porém com menor freqüência com curso clínico tardio. No segundo experimento, doze coelhos foram submetidos à ablação cirúrgica do bulbo olfatório e posteriormente inoculados com o BHV-5 pela via intranasal. Onze de 12 coelhos controle (91,6%), não submetidos à cirurgia, desenvolveram a doença neurológica, contra quatro de 12 (33,3%) dos animals submetidos à remoção cirúrgica do bulbo olfatório. Esses resultados demonstram que o sistema olfatório constitui-se na principal via de acesso do BHV-5 ao encéfalo de coelhos após inoculação intranasal. No entanto, o desenvolvimento de infecção neurológica em coelhos inoculados pela via conjuntival e em coelhos sem o bulbo olfatório indica que o BHV-5 pode utilizar outras vias para invadir o SNC, provavelmente as fibras sensoriais e autonômicas que compõe o nervo trigêmeo. Os efeitos da imunização com vírus homólogo (BHV-5) e heterólogo (BHV-1) na proteção à infecção neurológica foram investigados. Cinco entre 10 coelhos (50%) imunizados com o BHV-5 apresentaram sinais neurológicos discretos e transitórios e um morreu após o desafio com o BHV-5. Curiosamente, o grau de proteção foi superior nos coelhos imunizados com o BHV-1: apenas dois animais apresentaram sinais clínicos passageiros e recuperaram-se. Portanto, proteção da enfermidade neurológica pelo BHV-5 em coelhos pode ser obtida por imunização com o BHV-5 ou BHV-1, provavelmente devido à extensa reatividade sorológica cruzada entre esses vírus. Estudos adicionais em coelhos podem auxiliar no esclarecimento da patogênese e resposta imunológica a infecção pelo BHV-5.

Bovine herpesvirus type 1 (BoHV-1) causes respiratory and reproductive disorders in cattle. Recently, bovine herpesvirus type 5 (BoHV-5) and bovine herpesvirus type 4 (BoHV-4) have been identified to be associated with genital disease. In this study, the presence of the genome of BoHV-1, BoHV-4 and BoHV-5 in bovine semen of Argentinean and international origin was analyzed by PCR assays. The most important finding of this study is the detection of the genome of BoHV-1 and BoHV-4 in semen of bulls maintained at artificial insemination centers. It is particularly relevant that BoHV-1 DNA was also identified in one sample of international origin suggesting the need for extensive quality control measures on international transport of bovine semen.

Bovine herpes virus type 1 (BHV-1), the causative agent of infectious bovine rhinotracheitis, is a DNA virus. This pathogen is represents the most common viral pathogen found in cattle semen. The aim of the present study was to set up a of BHV-1 detection assay in bovine blood in Lorestan province using PCR assay. The blood samples of 285 cattle in Khoramabad, Azna, Aligoodarz, Borujerd and Poldokhtar were collected, total DNA was extracted and the region encoded the gI glycoprotein was amplified by PCR using specific primers. Out of 285 blood samples, 56 (19.64%) were positive for BHV-1 (468 bp). The highest and lowest frequencies of the bacterial infection were observed in Khoramabad and Borujerd cities with 21 and 12%, respectively. The results of this study demonstrated that PCR assay represent an excellent (suitable) alternative or additional tool for BHV-1 isolates detection. Finally the study revealed a high incidence of BHV-1 in the blood of Iranian cattle. Thus all cattle must be tested periodically for BHV-1 infection and antimicrobial drugs, to prevent BHV-1 occurrence in cattle must be used. The cattle must be free BHV-1 infection prior to use.

Identification of the US3 gene product of BHV-1 as a protein kinase and characterization of BHV-1 mutants of the US3 gene

Bovine herpesvirus type 5 (BHV-5) infection in calves causes meningoencephalitis, a fatal disease highly prevalent in South America. To study the pathogenesis of BHV-5 infection in cattle, 12 calves (group 1: acute infection) and 11 calves (group 2: latent infection) were intranasally inoculated with an Argentinean BHV-5 isolate at 10(8) and 10(4.7) tissue culture infective doses, respectively; six calves (control group) were mock infected. At 3 months postinoculation, all of the calves in group 2 and three calves in group 3 were given dexamethasone to reactivate the virus. The animals were euthanatized between days 6 and 17 postinoculation (group 1) and between days 6 and 16 postreactivation (group 2). Seventy-five percent and 91% of animals in groups 1 and 2, respectively, excreted BHV-5 in nasal and ocular discharges. Following dexamethasone administration, 45% of calves shed virus in both types of secretions. Spontaneous virus reactivation and shedding was observed in one calf. Neurologic signs consisting of circling, teeth grinding, ptyalism, jaw chomping, tongue protrusion, and apathy were observed in two animals in group 1 and, during the reactivation period, in four animals in group 2. Macroscopic findings consisted of softening of the cerebral tissue, meningeal hemorrhages and swelling, and edema and hemorrhages of prescapular, retropharyngeal and submandibular lymph nodes. Histologic lesions consisted of meningitis, mononuclear perivascular cuffing, neuronophagia, satellitosis, gliosis, hemorrhage, and necrosis and edema. Lesions in anterior cerebral cortex, medulla, and pons were consistently seen in all the animals of group 1. In the acutely infected animals, lesions in the diencephalon appeared at day 10 postinoculation, whereas in the latently infected calves these lesions were observed as early as at day 6 postreactivation. Latently infected animals developed lesions simultaneously in anterior cortex, medulla, pons, and diencephalon, showing a remarkable difference from the acutely infected group. Trigeminal ganglionitis appeared relatively early in animals of both groups (day 7 postinoculation in group 1 and day 8 postreactivation in group 2).